Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Interventional × Clinical Protocols × Clear all

Phase

Phase 2 13 Phase NA 4 Phase 3 3 Phase 4 2 Phase EARLY_PHASE1 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

Magnetic Resonance Spectroscopy 51 Cyclophosphamide 49 pembrolizumab 36 fludarabine 33 Radiotherapy 27 Biopsy 25 Nivolumab 22 Metformin 20 Bevacizumab 20 Fluorodeoxyglucose F18 19 Specimen Handling 18 Cisplatin 14 Temozolomide 13 Radiosurgery 13 Carboplatin 13 Paclitaxel 12 Fluorouracil 12 Dexamethasone 12 durvalumab 11 Radiation 11 gallium 68 PSMA-11 10 Rituximab 10 Letrozole 10 Gemcitabine 10 Etoposide 10 Doxorubicin 10 atezolizumab 9 X-Rays 9 Standard of Care 9 Irinotecan 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05141474 2024-11-07

NEXTGENTIL-ACT

Vall d'Hebron Institute of Oncology

Phase EARLY_PHASE1 Recruiting

Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡